SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-002780
Filing Date
2023-03-03
Accepted
2023-03-03 16:38:05
Documents
13
Period of Report
2023-03-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230303x8k.htm   iXBRL 8-K 60694
2 EX-3.1 elev-20230303xex3d1.htm EX-3.1 368500
  Complete submission text file 0001558370-23-002780.txt   612644

Data Files

Seq Description Document Type Size
3 EX-101.SCH elev-20230303.xsd EX-101.SCH 3064
4 EX-101.LAB elev-20230303_lab.xml EX-101.LAB 17333
5 EX-101.PRE elev-20230303_pre.xml EX-101.PRE 11106
7 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230303x8k_htm.xml XML 5186
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 23704930
SIC: 2836 Biological Products, (No Diagnostic Substances)